Rachel A. Kahler, Ph.D.

Affiliations: 
2006 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology
Google:
"Rachel Kahler"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Jennifer Westendorf grad student 2006 UMN
 (The role of lymphocyte enhancer -binding factor 1 (Lef1) in osteoblast differentiation.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hoeppner LH, Secreto F, Jensen ED, et al. (2009) Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation. Journal of Cellular Physiology. 221: 480-9
Kahler RA, Yingst SM, Hoeppner LH, et al. (2008) Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation. Matrix Biology : Journal of the International Society For Matrix Biology. 27: 330-8
Galindo M, Kahler RA, Teplyuk NM, et al. (2007) Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts. Journal of Molecular Histology. 38: 501-6
Kahler RA, Galindo M, Lian J, et al. (2006) Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. Journal of Cellular Biochemistry. 97: 969-83
Westendorf JJ, Kahler RA, Schroeder TM. (2004) Wnt signaling in osteoblasts and bone diseases. Gene. 341: 19-39
Schroeder TM, Kahler RA, Li X, et al. (2004) Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. The Journal of Biological Chemistry. 279: 41998-2007
Zeliadt NA, Warmka JK, Winston SE, et al. (2004) Tumor promoter-induced MMP-13 gene expression in a model of initiated epidermis. Biochemical and Biophysical Research Communications. 317: 570-7
Bose N, Kahler RA, Li X, et al. (2004) Impaired In Vitro Osteogenesis in Multiple Myeloma Bone Marrow Osteoprogenitor Cells. Blood. 104: 2349-2349
Kahler RA, Westendorf JJ. (2003) Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. The Journal of Biological Chemistry. 278: 11937-44
Westendorf JJ, Zaidi SK, Cascino JE, et al. (2002) Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Molecular and Cellular Biology. 22: 7982-92
See more...